Market Tracker

09/23 5:16pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

11.41
Delayed Data
As of Sep 23
 -0.21 / -1.81%
Today’s Change
10.14
Today|||52-Week Range
29.86
-52.77%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close11.62
Today’s open11.64
Day’s range11.40 - 11.80
Volume868,866
Average volume (3 months)994,030
Market cap$439.3M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+5.80%
Earnings growth (this year)+8.92%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.29%
P/E ratioNM
Price/Sales196.15
Price/Book2.34

Competitors

 Today’s
change
Today’s
% change
OMEDOncoMed Pharmaceutic...-0.26-2.11%
SRNESorrento Therapeutic...-0.10-1.27%
ADXSAdvaxis Inc-0.18-1.64%
ARNAArena Pharmaceutical...-0.03-1.69%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$4.1M
Annual profit (last year)-$106.8M
Net profit margin-2,636.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts